Evidence map›Paper›PMID 40670612›Full record

ArticleScientific reports2025

Green first derivative synchronous spectrofluorimetric determination of lacidipine and its acid degradation product in plasma and mixtures.

Khalid A M Attia, Mohamed A Hasan, Abdalla M El-Shanawany

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Khalid A M AttiaPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, 11751, Cairo, Egypt.
Mohamed A HasanPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, 11751, Cairo, Egypt. mohamedabdallah_87@yahoo.com.
Abdalla M El-ShanawanyPharmacist at Al-Azhar University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the main objectives of this study is to find an analysis method that has a low environmental and health impact and contributes to achieving sustainability. A simple and sensitive method was established for determination of lacidipine in pure active pharmaceutical ingredient, pharmaceutical formulation and spiked human plasma in presence of its acid induced degradation product. The native emission was measured at 430 nm after the excitation at 281 nm. A 0.5% Tween-80 solution was used to enhance fluorescence intensity. Peak amplitude of the first derivative synchronous was measured at 409 nm by using constant wavelength difference (Δλ = λ

Indexed as

DihydropyridinesHumansLimit of DetectionSpectrometry, FluorescenceDihydropyridineslacidipineLacidipinePharmaceutical PreparationSpiked human plasmaSynchronous fluorescence

Identifiers

PMID40670612
PMCPMC12267493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.